Neogen EBITDA Margin 2010-2024 | NEOG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Neogen (NEOG) over the last 10 years. The current EBITDA margin for Neogen as of August 31, 2024 is .
| Neogen EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-08-31 | $0.91B | $0.17B | 18.40% |
| 2024-05-31 | $0.93B | $0.18B | 19.89% |
| 2024-02-29 | $0.93B | $0.19B | 20.65% |
| 2023-11-30 | $0.92B | $0.19B | 21.00% |
| 2023-08-31 | $0.92B | $0.17B | 18.28% |
| 2023-05-31 | $0.82B | $0.13B | 15.94% |
| 2023-02-28 | $0.72B | $0.10B | 13.89% |
| 2022-11-30 | $0.63B | $0.07B | 10.95% |
| 2022-08-31 | $0.53B | $0.07B | 12.62% |
| 2022-05-31 | $0.53B | $0.08B | 15.56% |
| 2022-02-28 | $0.51B | $0.08B | 16.34% |
| 2021-11-30 | $0.50B | $0.09B | 18.29% |
| 2021-08-31 | $0.49B | $0.10B | 20.12% |
| 2021-05-31 | $0.47B | $0.10B | 20.30% |
| 2021-02-28 | $0.45B | $0.09B | 20.89% |
| 2020-11-30 | $0.43B | $0.09B | 21.02% |
| 2020-08-31 | $0.43B | $0.09B | 21.13% |
| 2020-05-31 | $0.42B | $0.09B | 20.81% |
| 2020-02-29 | $0.42B | $0.09B | 20.29% |
| 2019-11-30 | $0.42B | $0.09B | 20.62% |
| 2019-08-31 | $0.42B | $0.09B | 20.67% |
| 2019-05-31 | $0.42B | $0.09B | 20.72% |
| 2019-02-28 | $0.41B | $0.09B | 21.07% |
| 2018-11-30 | $0.41B | $0.09B | 21.46% |
| 2018-08-31 | $0.40B | $0.09B | 21.53% |
| 2018-05-31 | $0.40B | $0.09B | 21.61% |
| 2018-02-28 | $0.39B | $0.09B | 22.02% |
| 2017-11-30 | $0.38B | $0.08B | 21.90% |
| 2017-08-31 | $0.37B | $0.08B | 21.95% |
| 2017-05-31 | $0.36B | $0.08B | 22.01% |
| 2017-02-28 | $0.35B | $0.08B | 21.25% |
| 2016-11-30 | $0.34B | $0.07B | 20.76% |
| 2016-08-31 | $0.33B | $0.07B | 20.85% |
| 2016-05-31 | $0.32B | $0.07B | 21.43% |
| 2016-02-29 | $0.31B | $0.07B | 21.54% |
| 2015-11-30 | $0.30B | $0.07B | 22.52% |
| 2015-08-31 | $0.29B | $0.07B | 22.76% |
| 2015-05-31 | $0.28B | $0.06B | 22.61% |
| 2015-02-28 | $0.27B | $0.06B | 22.51% |
| 2014-11-30 | $0.27B | $0.06B | 22.26% |
| 2014-08-31 | $0.26B | $0.06B | 21.40% |
| 2014-05-31 | $0.25B | $0.05B | 21.37% |
| 2014-02-28 | $0.24B | $0.05B | 21.52% |
| 2013-11-30 | $0.23B | $0.05B | 22.12% |
| 2013-08-31 | $0.22B | $0.05B | 23.04% |
| 2013-05-31 | $0.21B | $0.05B | 23.08% |
| 2013-02-28 | $0.20B | $0.05B | 22.89% |
| 2012-11-30 | $0.20B | $0.04B | 22.05% |
| 2012-08-31 | $0.19B | $0.04B | 21.69% |
| 2012-05-31 | $0.19B | $0.04B | 21.62% |
| 2012-02-29 | $0.18B | $0.04B | 22.22% |
| 2011-11-30 | $0.18B | $0.04B | 22.60% |
| 2011-08-31 | $0.18B | $0.04B | 23.30% |
| 2011-05-31 | $0.17B | $0.04B | 23.70% |
| 2011-02-28 | $0.17B | $0.04B | 23.21% |
| 2010-11-30 | $0.16B | $0.04B | 23.13% |
| 2010-08-31 | $0.15B | $0.03B | 22.52% |
| 2010-05-31 | $0.14B | $0.03B | 22.14% |
| 2010-02-28 | $0.13B | $0.03B | 21.97% |
| 2009-11-30 | $0.13B | $0.03B | 21.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.605B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $194.987B | 24.87 |
| Stryker (SYK) | United States | $136.147B | 30.68 |
| Boston Scientific (BSX) | United States | $130.670B | 37.57 |
| EssilorLuxottica (ESLOY) | France | $110.026B | 0.00 |
| Medtronic (MDT) | Ireland | $102.570B | 15.24 |
| Haleon (HLN) | United Kingdom | $43.909B | 28.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.293B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.376B | 18.35 |
| ResMed (RMD) | United States | $33.995B | 27.93 |
| Terumo (TRUMY) | Japan | $28.800B | 40.67 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 18.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.064B | 13.41 |
| Insulet (PODD) | United States | $17.996B | 71.67 |
| Baxter (BAX) | United States | $14.756B | 9.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.838B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.021B | 40.32 |
| Bio-Rad Laboratories (BIO) | United States | $9.125B | 31.01 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.392B | 14.85 |
| Prestige Consumer Healthcare (PBH) | United States | $3.886B | 19.33 |
| Haemonetics (HAE) | United States | $3.862B | 18.85 |
| ICU Medical (ICUI) | United States | $3.751B | 35.71 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.33 |
| Envista Holdings (NVST) | United States | $3.103B | 23.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.894B | 18.63 |
| GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
| LeMaitre Vascular (LMAT) | United States | $2.074B | 50.41 |
| Green Thumb Industries (GTBIF) | United States | $1.630B | 28.52 |
| AtriCure (ATRC) | United States | $1.465B | 0.00 |
| InMode (INMD) | Israel | $1.444B | 8.68 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.371B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.32 |
| BioLife Solutions (BLFS) | United States | $1.211B | 0.00 |
| Owens & Minor (OMI) | United States | $0.973B | 7.60 |
| CeriBell (CBLL) | United States | $0.958B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.955B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| Omeros (OMER) | United States | $0.593B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 26.15 |
| Capricor Therapeutics (CAPR) | United States | $0.587B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Quanterix (QTRX) | United States | $0.383B | 0.00 |
| ZimVie (ZIMV) | United States | $0.373B | 31.44 |
| Valneva SE (VALN) | France | $0.353B | 0.00 |
| Biote (BTMD) | United States | $0.313B | 6.86 |
| Viemed Healthcare (VMD) | United States | $0.312B | 29.70 |
| Canopy Growth (CGC) | Canada | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.283B | 18.95 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Zynex (ZYXI) | United States | $0.268B | 56.00 |
| High Tide (HITI) | Canada | $0.237B | 98.00 |
| Aurora Cannabis (ACB) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.54 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Organigram Holdings (OGI) | Canada | $0.184B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| Brainsway (BWAY) | Israel | $0.169B | 89.60 |
| FitLife Brands (FTLF) | United States | $0.151B | 19.04 |
| Jin Medical (ZJYL) | China | $0.132B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.110B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.79 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Exagen (XGN) | United States | $0.083B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.17 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.82 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |